Induction and Evolution of Metaplasia in the Stomach
Induction and Evolution of Metaplasia in the Stomach
批准号:
8722082
负责人:
JAMES Richard GOLDENRING
金额:
$34.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2018-04-30
关键词:
AcuteAddressAdenocarcinomaAntralAtrophicCancer EtiologyCancerousCell LineCell LineageCellsCessation of lifeCharacteristicsChief CellChronicDevelopmentDysplasiaEarly DiagnosisEarly treatmentEventEvolutionFundingGastric Parietal CellsGene ExpressionGenerationsGenesGerbilsGlandGoblet CellsHelicobacterHelicobacter pyloriHumanImmigrantImmuneInflammationInflammatoryIntestinal MetaplasiaIntestinesInvestigationLeadLesionMalignant NeoplasmsMapsMediator of activation proteinMetaplasiaMetaplasticModelingMucous body substanceMusNeckNeoplasmsNeoplastic ProcessesPathway interactionsPatientsPhenotypePopulationProcessRiskRodent ModelRoleSmooth PursuitStem cellsStomachWorkcancer typegastric fundusimprovedinsightmacrophagemalignant stomach neoplasmmouse modelneoplasticnovelnovel strategiespromoterpublic health relevancescreeningspasmolytic polypeptidetherapy developmenttransdifferentiation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Adenocarcinoma in the human stomach evolves in the setting of Helicobacter pylori-
induced oxyntic atrophy and chronic mucous cell metaplasia. Our recent lineage
mapping studies have demonstrated that metaplasia in the gastric fundus in mice does
not arise from the professional progenitor cells located in the upper neck region of the
glands, but rather develops from transdifferentiation of mature chief cells into
Spasmolytic Polypeptide Expressing Metaplasia, or SPEM. These studies have led to a
significant paradigm shift in the concepts for the origin of gastric neoplasia, suggesting
that pre-neoplastic lineages do not arise from professional resident mucosal progenitor
cell populations, but rather develop from transdifferentiation of mature zymogenic cell
lineages. Furthermore, multiple studies now indicate that SPEM, under the influence of
inflammation, can develop both increased proliferation and increasing levels of
intestinalizing gene expression, and in humans gives rise to goblet cell intestinal
metaplasia. Our recent investigations have demonstrated that macrophages are
responsible for the promotion of proliferative SPEM progression, but the precise
mediators that are responsible for the progression of SPEM towards intestinalization and
dysplasia remain unknown. We therefore hypothesize that discrete intrinsic mucosal and
macrophage-derived factors regulate not only the evolution, but also the progression of
SPEM to more proliferative, preneoplastic metaplasia. To address this hypothesis, we
will pursue two specific aims: First, we will examine the role of macrophages in the
evolution and progression of metaplasia. Second, we will evaluate the role of Ras
activation in evolution of SPEM from transdifferentiating chief cells and the further
intestinalization of SPEM lineages in a novel model of metaplasia driven by inducible
expression of activated K-Ras in chief cells. While our previous investigations have
focused on the establishment of a novel pathway for generation of metaplasia through
transdifferentiation of chief cells, the present investigations now focus on the
mechanisms that might drive metaplasias to preneoplasia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
-
批准号:10013219
-
项目类别:
-
资助金额:$176.49万
-
财政年份:2019
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
-
批准号:10200797
-
项目类别:
-
资助金额:$174.66万
-
财政年份:2019
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
-
批准号:10683735
-
项目类别:
-
资助金额:$169.98万
-
财政年份:2019
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
-
批准号:9815928
-
项目类别:
-
资助金额:$185.19万
-
财政年份:2019
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
COngenital Diarrhea and Enteropathy (PediCODE) Consortium and BioRepository
-
批准号:10472774
-
项目类别:
-
资助金额:$171.5万
-
财政年份:2019
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Generating a Porcine Model for Human Microvillus Inclusion Disease (MVID) by Gene Editing
-
批准号:9141460
-
项目类别:
-
资助金额:$39.47万
-
财政年份:2016
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Mouse model of invasive colon cancer
-
批准号:8878756
-
项目类别:
-
资助金额:$20.49万
-
财政年份:2015
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Arcturus XT-TI Laser Capture Microdissection Instrument
-
批准号:8948705
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Mouse model of invasive colon cancer
-
批准号:9248192
-
项目类别:
-
资助金额:$15.75万
-
财政年份:2015
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Mouse model of invasive colon cancer
-
批准号:9043831
-
项目类别:
-
资助金额:$1.42万
-
财政年份:2015
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Induction and Evolution of Metaplasia in the Stomach
-
批准号:9278155
-
项目类别:
-
资助金额:$34.33万
-
财政年份:2014
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Induction and Evolution of Metaplasia in the Stomach
-
批准号:9916731
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2014
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Gastrointesinal Stem Cell Meeting
-
批准号:8399957
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2012
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:8244937
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:8398926
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:8696796
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:10554305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:9884861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:8141557
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
Oxyntic Atrophy and Novel Gastric Lineages
-
批准号:9057852
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:JAMES Richard GOLDENRING
-
依托单位:
海外基金